Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines
Mr. Posner et al., Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines, CLIN CANC R, 5(8), 1999, pp. 2261-2270
Because regional spread to lymph nodes without systemic spread is a relativ
ely common event in squamous cell cancer of the head and neck (SCCHN), it i
s possible that lymphoid-related receptors or cytokines might directly impa
ct the growth of these tumors. In the present study, we have shown by flow
cytometry and Western blotting that the central lymphoid regulatory molecul
e, CD40, is expressed on the surface of all seven SCCHN tumor cell lines st
udied. Tumor cell lines also expressed epidermal growth factor (EGF) recept
or, MHC class I, and CD95 (Fas) but did not uniformly express other importa
nt lymphoid regulatory molecules such as CD80, CD86, or interleukin (IL) 2
receptor components. CD40 ligation by trimeric CD40 ligand (CD40L) resulted
in a 20-45% inhibition of tumor cell growth in three of seven cell lines t
ested. The cytokines IL-1 alpha, IL-1 beta, IL-2, IL-4, IL-6, IL-10, IL-11,
and IL-15 neither inhibited nor stimulated growth in any of the cell lines
tested. EGF had pleiotropic effects on cell growth; it inhibited growth in
two cell lines, stimulated growth in one cell line, and had no effect in f
our cell lines. When coligation by EGF and CD40L was studied, additive or s
upra-additive growth inhibition was seen in four cell lines. Three cell lin
es were unaffected by EGF, CD40, or coligation with both reagents, Examinat
ion of tumor tissues from 12 previously untreated patients representing a b
road spectrum of patients presenting with SCCHN demonstrated CD40 expressio
n in all 12 tumor specimens. This study supports the notion that CD40 is a
regulatory molecule for the growth of SCCHN. The important role of CD40-CD4
0L interactions in the regulation of immune cells in the lymph node and the
unique high-level expression of CD40L by these immune cells lend support t
o the hypothesis that this ligand/receptor pair is an important mediator of
cell growth in SCCHN.